NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors - Wang-Gillam, A; Hubner, RA; Siveke, JT (Eur J Cancer, 2019)
et al.